NCT02794636View on ClinicalTrials.gov

Interferon Toxicities in Melanoma Treatment

CompletedOBSERVATIONAL
Enrollment

436

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Stage III Melanoma
Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02794636 - Interferon Toxicities in Melanoma Treatment | Biotech Hunter | Biotech Hunter